Direxion Daily S&P Biotech Bull 3x Shares $LABU Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC trimmed its holdings in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABUFree Report) by 80.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 701 shares of the company’s stock after selling 2,910 shares during the quarter. SG Americas Securities LLC’s holdings in Direxion Daily S&P Biotech Bull 3x Shares were worth $112,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in LABU. Tower Research Capital LLC TRC boosted its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 664.7% in the third quarter. Tower Research Capital LLC TRC now owns 58,171 shares of the company’s stock valued at $5,445,000 after acquiring an additional 50,564 shares during the period. IMC Chicago LLC acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter valued at approximately $3,806,000. Squarepoint Ops LLC boosted its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 33.2% in the second quarter. Squarepoint Ops LLC now owns 161,146 shares of the company’s stock valued at $9,171,000 after acquiring an additional 40,157 shares during the period. JPMorgan Chase & Co. acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter valued at approximately $3,208,000. Finally, Virtu Financial LLC acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter valued at approximately $1,757,000.

Direxion Daily S&P Biotech Bull 3x Shares Price Performance

LABU stock opened at $210.82 on Friday. Direxion Daily S&P Biotech Bull 3x Shares has a twelve month low of $44.51 and a twelve month high of $212.45. The business has a 50 day simple moving average of $165.81 and a 200-day simple moving average of $153.84.

About Direxion Daily S&P Biotech Bull 3x Shares

(Free Report)

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.

Further Reading

Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABUFree Report).

Institutional Ownership by Quarter for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)

Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.